Powered by LumidaWealth.com
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
  • Home
  • EarningsNEW
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us
No Result
View All Result
Lumida News
No Result
View All Result
  • Lumida Wealth
  • Lumida Ledger
  • LUMIDA ETF
  • About Us
Home Themes AI

EssilorLuxottica Acquires AI-Driven Ophthalmology Platform Optegra to Expand Medical Technology Portfolio

by Team Lumida
May 30, 2025
in AI
Reading Time: 4 mins read
A A
0
EssilorLuxottica Acquires AI-Driven Ophthalmology Platform Optegra to Expand Medical Technology Portfolio
Share on TelegramShare on TwitterShare on FacebookShare on LinkedinShare on Whatsapp

Key Takeaways:

Powered by lumidawealth.com

  • EssilorLuxottica, the maker of Ray-Ban, announced plans to acquire Optegra, an AI-focused ophthalmology platform operating over 70 eye hospitals across Europe.
  • The acquisition aligns with EssilorLuxottica’s strategy to expand beyond eyewear into AI-powered medical technologies, wearables, and science-backed eyecare solutions.
  • Optegra specializes in ophthalmic treatments and elective vision correction procedures, leveraging AI in pre- and postoperative care.
  • The financial terms of the deal were not disclosed, and the transaction is expected to close later this year, pending regulatory approval.

What Happened?

EssilorLuxottica, the Franco-Italian eyewear giant known for its Ray-Ban brand, announced its acquisition of Optegra, a leading AI-driven ophthalmology platform. Optegra operates a network of over 70 eye hospitals and diagnostic facilities across the U.K., Czech Republic, Poland, Slovakia, and the Netherlands.

The acquisition is part of EssilorLuxottica’s broader push into medical technology, complementing its existing portfolio of frames, lenses, and AI-powered solutions. Optegra’s expertise in ophthalmic treatments and vision correction, supported by artificial intelligence, will enhance EssilorLuxottica’s capabilities in delivering advanced eyecare solutions.

This move follows EssilorLuxottica’s extended partnership with Meta last year to develop smart Ray-Ban glasses, further demonstrating its commitment to integrating AI into its product offerings.


Why It Matters?

The acquisition of Optegra underscores EssilorLuxottica’s strategic shift toward medical technology and AI-driven solutions, positioning the company as a leader in both consumer eyewear and advanced eyecare. By integrating AI into ophthalmic treatments, EssilorLuxottica aims to address growing demand for precision medicine and innovative healthcare solutions.

For Optegra, the deal provides access to EssilorLuxottica’s global resources and expertise, enabling it to scale its operations and expand its impact in the field of ophthalmology.

This acquisition also highlights the increasing convergence of technology and healthcare, as companies leverage AI to improve patient outcomes and streamline medical processes.


What’s Next?

The transaction is expected to close later this year, pending regulatory approvals. EssilorLuxottica will focus on integrating Optegra’s AI-driven capabilities into its existing medical technology portfolio, potentially expanding its reach into new markets.

Investors and industry stakeholders will monitor how this acquisition enhances EssilorLuxottica’s competitive edge in the growing medical technology and AI sectors. Additionally, the company’s ongoing collaboration with Meta on smart glasses could further benefit from Optegra’s expertise in AI and vision care.

Source
Previous Post

Chinese Tech Stocks Slide as U.S.-China Trade Talks Stall

Next Post

Trump Pressures Fed Chair Powell to Cut Interest Rates, Citing Economic Disadvantage

Recommended For You

California Attorney General Rob Bonta Issues a Subpoena to Nvidia Over Whether Advanced Chips Reached China and Investors Were Misled

by Team Lumida
14 hours ago

California AG Rob Bonta issued an investigative subpoena to Nvidia on Thursday over whether advanced chips reached China and whether investors were misled.

Read more

U.S. Approved Nearly 880,000 AI Chip Sales to Chinese Firms Including Tencent and Alibaba, House Data Show

by Team Lumida
14 hours ago

House data show the U.S. approved nearly 880,000 AI chip sales to China, including shipments for Tencent and Alibaba, after Nvidia and AMD sought 3.4 million.

Read more

Anthropic Closes at $88.91, Down 8.5% on Its Second Day, After a Debut High Above $115, as the IPO Fails to Revive the AI Trade

by Team Lumida
14 hours ago

Anthropic fell 8.5% to $88.91 on its second session, giving back much of Thursday’s 17% debut gain, as valuation anxiety kept the AI trade under pressure.

Read more

Trump Says the US Could Let Nvidia Sell Blackwell Chips to China in ‘Two Years or Three Years,’ Calling the H200 ‘Semi-Obsolete’ as Congress Moves to Bar Sales for 18 Months

by Team Lumida
2 days ago

Trump said Nvidia could sell Blackwell chips to China in two or three years, as senators push the AI Overwatch Act to bar such sales for at least...

Read more

Intel Signs Its First Outside Customer for 18A Chips and Names Microsoft as Its First Public Customer for EMIB Packaging, After Losing More Than Half Its Value Since September

by Team Lumida
2 days ago
Intel Surges 5%, SK Hynix Up 3% on Reports of U.S. Memory Chip Manufacturing Deal to Serve Nvidia and AI Demand

Intel CEO Lip-Bu Tan said the company signed its first outside customer for 18A chips and named Microsoft as its first public EMIB packaging customer.

Read more

China’s Military Is ‘Actively Soliciting’ Nvidia’s Most Advanced Chips for AI-Enabled Military Capabilities, a Congressional Commission Says in Its 2026 Report

by Team Lumida
3 days ago

A congressional commission said China’s military is seeking advanced Nvidia chips and evading export controls, including via data centers in Malaysia.

Read more

Bipartisan Push to Attach AI Chip Export Limits to the December NDAA Gains Steam After the Huang Affair, With Schumer, Jeffries and Speaker Johnson Backing the AI Overwatch, MATCH and Chip Security Acts

by Team Lumida
3 days ago

Lawmakers from both parties are pushing three chip export bills into the December defense bill after Jensen Huang’s resignation, but time is short.

Read more

Banks Pause a $480 Million Nvidia GPU Loan to Aolani Cloud Tied to ByteDance After New US Licensing Rules for Malaysia and Singapore Data Centers

by Team Lumida
4 days ago
ByteDance Is Buying Custom Chips From Taiwan Because It Cannot Buy Nvidia’s, Which US Rules Permit

Banks paused or reconsidered a $480 million Aolani Cloud loan for Nvidia GPUs tied to ByteDance after new US licensing rules, Bloomberg reported.

Read more

Commerce and Justice Say They Began Investigating Nvidia Partner Megaspeed in 2024, as Critics Ask Why It Kept Getting Chips After Nvidia’s ‘No Sell’ Listing

by Team Lumida
4 days ago

Commerce and Justice said they opened export-control probes into Megaspeed in 2024 and inspected it in June 2025, as critics question how it kept buying chips.

Read more

Nvidia Warns Chip Buyers That the Remote Access Security Act Could Expose Them to US ‘Legal Action’ and Caps Sales to Clouds Renting Over 50% of GPUs to Chinese Firms

by Team Lumida
4 days ago

Nvidia cautioned customers that the proposed Remote Access Security Act could bring US legal action over Chinese cloud access to its chips, CNBC reported.

Read more
Next Post
Will September’s Fed Rate Cuts Surprise Investors? Here’s What Deutsche Bank Predicts

Trump Pressures Fed Chair Powell to Cut Interest Rates, Citing Economic Disadvantage

Costco Mitigates Tariff Impact Through Strategic Sourcing and Order Advancements

Costco Mitigates Tariff Impact Through Strategic Sourcing and Order Advancements

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

a white square with a blue logo on it

Meta Is Building a Cloud Business to Sell Excess AI Compute — Challenging AWS, Azure, and Google Cloud

July 1, 2026
Toyota Joins Forces to Revolutionize EV Charging in North America

Toyota Joins Forces to Revolutionize EV Charging in North America

July 11, 2024
Goldman-Linked Oncoclinicas Implodes in Brazilian Governance Crisis; $990M Debt Restructuring; Banco Master Exposure; Two Goldman Employees Named Fraud Suspects

Goldman-Linked Oncoclinicas Implodes in Brazilian Governance Crisis; $990M Debt Restructuring; Banco Master Exposure; Two Goldman Employees Named Fraud Suspects

September 23, 2026

Subscribe to Lumida Ledger

Browse by Category

  • Lifestyle
    • Family Office
    • Health and Longevity
    • Legacy
    • Next Gen Wealth
    • Trust, Tax, and Estate
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Latest
    • Macro
    • Markets
    • Real Estate
  • Opinions
    • Investing Philosophy
    • Op-Ed
  • Research
    • Trackers
  • Themes
    • Aging & Longevity
    • AI
    • Biotech
    • CRE
    • Cybersecurity
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
    • Software
Facebook Twitter Instagram Youtube TikTok LinkedIn
Lumida News

Premium insights to help you invest beyond the ordinary. Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser

CATEGORIES

  • Aging & Longevity
  • AI
  • Alt Assets
  • Biotech
  • CRE
  • Crypto
  • Cybersecurity
  • Digital Assets
  • Equities
  • Family Office
  • Health and Longevity
  • Investing Philosophy
  • Latest
  • Legacy
  • Legacy Brands
  • Lifestyle
  • Macro
  • Markets
  • News
  • Next Gen Wealth
  • Nuclear Renaissance
  • Op-Ed
  • Private Credit
  • Real Estate
  • Software
  • Themes
  • Trackers
  • Trust, Tax, and Estate

BROWSE BY TAG

AI AI chips Amazon Apple Artificial Intelligence Banking Bank of America China Commercial Real Estate CPI data centers Donald Trump EARNINGS ELON MUSK Federal Reserve financial services generative AI Goldman Sachs Google India Inflation Interest Rates Investment Strategy Japan Jerome Powell JPMorgan Markets Meta Microsoft Nasdaq Novo Nordisk Nuclear Energy Nvidia oil OpenAI private equity S&P 500 SEC Semiconductor stock market stock surge Tech Stocks tesla Trump Whale Watch

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018

No Result
View All Result
  • Home
  • Earnings
  • News
    • Alt Assets
    • Crypto
    • Equities
    • Macro
    • Markets
    • Real Estate
  • Lifestyle
    • Family Office
    • Health and Longevity
  • Themes
    • Aging & Longevity
    • AI
    • CRE
    • Digital Assets
    • Legacy Brands
    • Nuclear Renaissance
    • Private Credit
  • About Us

© 2025 Lumida Wealth Management LLC is an SEC registered investment adviser. Privacy Policy. Cookies Policy.
Disclaimer Important Information This site is for informational purposes only. Information presented on this site does not constitute as investment advice.

Lumida Wealth Management LLC (‘Lumida”) is an SEC registered investment adviser. SEC registration does not constitute an endorsement of the firm by the Commission nor does it indicate that the adviser has attained a particular level of skill or ability.

Lumida's website (referred to herein as the "Website") is limited to the dissemination of general information pertaining to its advisory services, together with access to additional investment-related information, publications, and links. Accordingly, the publication of the Website on the Internet should not be construed by any client and/or prospective client Lumida’s solicitation to effect, or attempt to effect transactions in securities, or the rendering of personalized investment advice for compensation, over the Internet.

Any subsequent, direct communication by Lumida with a prospective client will be conducted by a representative that is either registered or qualifies for an exemption or exclusion from registration in the state where the prospective client resides.

‍Lead Capture Forms: By submitting your contact information in the forms on this site, you are not obligated to invest in Lumida's product or services.
‍Address: Lumida Wealth Management, 25 W 39th Street Suite 700, New York, NY 10018